1.

Approval of new drug and/or medical device, and dissemination of R&D results of the QiSS consortium

2.

International standardization to evaluate the soft error caused by the cosmic ray, and dissemination of R&D results of the QiSS consortium

3.

In and Out licensing of R&D assets of the QiSS consortium, and Issuing the Certificate for the evaluated electric devices for the soft error, also for the skill and knowledge of the trained students in the Association support business

4.

Supply business of the radioisotope medicine and/or their active pharmaceutical ingredients

5.

Human resource development and dissemination of the related technologies related for the Association Business